ORCID: https://orcid.org/0000-0003-3580-2313; Stintzing, Sebastian ORCID: https://orcid.org/0000-0002-3297-5801; Weikersthal, Ludwig Fischer von; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Kaiser, Florian; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christoph; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank ORCID: https://orcid.org/0000-0001-5575-1010; Moehler, Markus; Scheithauer, Werner; Jung, Andreas ORCID: https://orcid.org/0000-0001-5270-9108; Holch, Julian W. ORCID: https://orcid.org/0000-0002-4755-0179; Held, Swantje; Modest, Dominik Paul und Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321
(2026):
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer – A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.
In: European Journal of Cancer, Vol. 232, 116133
[PDF, 2MB]
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine > Medical Center of the University of Munich > Medical Clinic and Outpatient Clinic III (Oncology) |
| Subjects: | 600 Technology > 610 Medicine and health |
| URN: | urn:nbn:de:bvb:19-epub-131025-2 |
| ISSN: | 09598049 |
| Language: | English |
| Item ID: | 131025 |
| Date Deposited: | 14. Jan 2026 06:51 |
| Last Modified: | 10. Apr 2026 07:14 |
Actions (login required)
- View Item
